Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

The signaling landscape of insulin-like growth factor 1

Skip to main contentSkip to article View PDF Under a Creative Commons license Open access The sheer amplitude of biological actions of insulin-like growth factor I (IGF-1) affecting all types of cells in all tissues suggests a vast signaling landscape for this ubiquitous humoral signal. While the canonical signaling pathways primarily involve the Ras/MAPK and PI3K/AKT cascades, the evolutionary conservation of insulin-like peptides (ILPs) and their pathways hints at the potential for novel functions to emerge over time. Indeed, the evolutionary trajectory of ILPs opens the possibility of either novel functions for these two pathways, novel downstream routes, or both. Evidence supporting this notion includes observations of neofunctionalization in bony fishes or crustaceans, and the involvement of ILPs pathways in invertebrate eusociality or in vertebrate bone physiology, respectively. Such evolutionary processes likely contribute to the rich diversity of ILPs signaling observed today.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Skip to main contentSkip to article

View PDF

Under a Creative Commons license

Open access

The sheer amplitude of biological actions of insulin-like growth factor I (IGF-1) affecting all types of cells in all tissues suggests a vast signaling landscape for this ubiquitous humoral signal. While the canonical signaling pathways primarily involve the Ras/MAPK and PI3K/AKT cascades, the evolutionary conservation of insulin-like peptides (ILPs) and their pathways hints at the potential for novel functions to emerge over time. Indeed, the evolutionary trajectory of ILPs opens the possibility of either novel functions for these two pathways, novel downstream routes, or both. Evidence supporting this notion includes observations of neofunctionalization in bony fishes or crustaceans, and the involvement of ILPs pathways in invertebrate eusociality or in vertebrate bone physiology, respectively. Such evolutionary processes likely contribute to the rich diversity of ILPs signaling observed today. Moreover, the interplay between conserved signaling pathways, such as those implicated in aging (predominantly involving the PI3K-AKT route), and lesser known pathways, such as those mediated by biased G-protein coupled receptors and others even less known, may underpin the context-dependent actions characteristic of ILPs signaling. While canonical IGF-1 signaling is often assumed to account for the intracellular pathways utilized by this growth factor, a comprehensive analysis of all the pathways mediated by the IGF-1 receptor (IGF-1R) remains lacking. This review aims to explore both canonical and non-canonical routes of IGF-1R action across various cell types, offering a detailed examination of the mechanisms underlying IGF-1 signaling and highlighting the significant gaps in our current understanding.

Keywords

insulin-like growth factor

signaling

insulin receptor substrate 1 (IRS-1)

phosphatidylinositide-3 kinase (PI3K)

AKT (PKB)

Ras protein

Abbreviations

CREB

cAMP response element-binding protein

eNOS

Endothelial nitric oxide synthase

Elk

Ets-like Kinase

FSH

Follicle stimulating hormone

GluT

Glucose transporter

GSK3

Glycogen synthase kinase 3

IGF-1

Insulin-like growth factor 1

IRS

Insulin receptor substrate

LRP

Low-density lipoprotein receptor-related protein

LH

Luteinizing hormone

LPA

Lysophosphatidic acid

mTOR

Mammalian target of rapamycin

MAPK

Mitogen activated protein kinase

MCT

Monocarboxylate transporter

NFκB

Nuclear factor kappa-light-chain-enhancer of activated B cells

NFAT

Nuclear factor of activated T-cells

PTEN

Phosphatase and tensin homolog

PI3K

Phosphatidylinositide-3 kinase

PKC

Protein kinase C

RACK

Receptor for activated C kinase

STAT

Signal transducer and activator of transcription

Shc

Src homolog and collagen domain protein

TSH

Thyroid stimulating hormone

TRPV4

Transient receptor potential vanilloid 4

Wnt

Wingless-Int

© 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.

Connected topics

Follow this recovery question